🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective is to assess differences in PASI scores between Week ...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00329303
Treatments Being Tested
The primary purpose is to assess whether there is transfer of Certolizumab ...
Status
Completed
Location
11
Start Date
2014-01
Trial ID
NCT02019602
This prospective, post marketing, observational, Noninterventional Study (N...
Status
Completed
Location
039
Start Date
2012-12
Trial ID
NCT01764321
RABIOPRED is an in vitro non-invasive blood test, which aims to identify pa...
Status
Terminated
Location
Institute of Rheumatology
Start Date
2016-12
Trial ID
NCT03016260
The purpose of the study is to better understand the factors present in the...
Status
Completed
Location
Outpatient Care Center
Start Date
2015-08
Trial ID
NCT02451748
To determine if early clinical response at 12 weeks to Certolizumab Pegol (...
Status
Completed
Location
2
Start Date
2011-07
Trial ID
NCT01288287
Phase IIIb study to determine early response to Certolizumab Pegol (CZP) wi...
Status
Completed
Location
003
Start Date
2010-12
Trial ID
NCT01235598
Treatments Being Tested
To compare the bioavailability of a single 400 mg dose of certolizumab pego...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00845663
Treatments Being Tested
The purpose of this study is to monitor safety outcomes of patients who hav...
Status
Completed
Location
C87075 931
Start Date
2009-01-30
Trial ID
NCT00844285
Treatments Being Tested
This is a phase 3, multicenter, randomized, open, prospective, controlled, ...
Status
Unknown
Location
Asklepios Klinikum Bad Abbach
Start Date
2009-01
Trial ID
NCT02779114
Treatments Being Tested